Skip Navigation

Immune Checkpoint Inhibitor Toxicity I-CHECKIT: A Prospective Observational Study

Brief Summary

Type:
Other

Study Type:
Supportive Care

Phase:
IV

ClinicalTrials.gov Identifier:
NCT04871542

Study #:
STUDY00148875

Start Date:
Oct 03, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04871542

View Complete Trial Details & Eligibility at ClinicalTrials.gov